84: Quality of life measures relating to the skin toxicities of tyrosine kinase inhibitor (TKI) use in lung cancer – what is in current use in the literature?

Saved in:
Bibliographic Details
Published inLung cancer (Amsterdam, Netherlands) Vol. 87; p. S33
Main Authors Watts, G.J, Nelson, A, Lester, J.F, Noble, S.I
Format Journal Article
LanguageEnglish
Published Elsevier Ireland Ltd 2015
Subjects
Hematology, Oncology and Palliative Medicine
Pulmonary/Respiratory
Online AccessGet full text

Cover

More Information
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(15)50083-4